Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 71610-907

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 71610-907). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0907 45)

Label (71610 0907 45)
Label for Cyclobenzaprine Hydrochloride USP 10 mg film-coated tablets, containing 45 tablets. The label includes storage instructions, manufacturer information (AvKare, Inc., Pulaski, TN), and the labeler Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN. It notes the product is for prescription use only with an NDC of 71610-907-45.*
FDA Label Image

Aphena (Aphena)

FDA Label Image

Cyclobenzaprine (Cyclobenzaprine Structure)

Cyclobenzaprine (Cyclobenzaprine Structure)
Chemical structure of Cyclobenzaprine Hydrochloride, a skeletal formula showing the arrangement of its atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.